NCT03382665View on ClinicalTrials.gov

Post-market Surveillance Study With the HYPERION Hip Endoprosthesis System in Defect Reconstruction

TerminatedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

August 31, 2017

Study Completion Date

March 31, 2018

Conditions
OsteoarthritisAvascular NecrosisRheumatoid ArthritisFunctional DeformitiesPseudoarthrosisRevision of Endoprosthesis-treated HipsFracture, Proximal HumeralProvision of Non-endoprosthetic Previous Operations of the Hip Joint (e.g., Transposition Osteotomies)Femur FracturePseudarthrosisTrochanteric FracturesBridging of Large Bone DefectsRevisions
Trial Locations (3)

31135

Helios Klinik Hildesheim, Hildesheim

49076

Klinikum Osnabrück GmbH, Osnabrück

92421

Asklepios Orthopädische Klinik Lindenlohe, Schwandorf in Bayern

Sponsors

Lead Sponsor

Zimmer Biomet
All Listed Sponsors
lead

Zimmer Biomet

INDUSTRY

NCT03382665 - Post-market Surveillance Study With the HYPERION Hip Endoprosthesis System in Defect Reconstruction | Biotech Hunter | Biotech Hunter